QL2107, PEMBROLIZUMAB
QL2107-102
Phase 3 small_molecule active
Quick answer
QL2107, PEMBROLIZUMAB for Non-small cell lung cancer is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Non-small cell lung cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active